These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3530620)

  • 1. [Therapeutic action of a new xanthine derivative in respiratory pathology].
    Cesco G; Biondi T; Mazzini R
    Clin Ter; 1986 Aug; 118(4):253-7. PubMed ID: 3530620
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bamifylline in the treatment of chronic bronchial obstruction: a controlled clinico-functional study versus an anhydrous theophylline administered once a day].
    Caputi M; Cautiero V; Aliberti M; Monici Preti PA; Oliani C
    Arch Monaldi Mal Torace; 1988; 43(5):409-21. PubMed ID: 3079283
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinico-functional study of the activity of a new xanthine derivative: bamifylline].
    Finiguerra M; Morandini GC
    Clin Ter; 1986 Jul; 118(2):125-35. PubMed ID: 3527540
    [No Abstract]   [Full Text] [Related]  

  • 4. [The grade of dyspnea in patients treated with a theophylline derivative (bamifylline) vs controlled-absorption theophylline].
    Giosuè S; Parola D; Cafaggi R; Astengo D; Greco G; D'Onofrio V
    Clin Ter; 1987 Dec; 123(6):457-63. PubMed ID: 2972503
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical efficacy trial: theophylline vs (dl) 3,7-dihydro-1,8-dimethyl-3-(2-methylbutyl)-1H-purine-2,6-dione.
    Grassi C; Casali L; Rampulla C; Rossi A
    Int J Clin Pharmacol Ther Toxicol; 1980 Dec; 18(12):518-22. PubMed ID: 7014478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bamifylline in the therapy of asthmatic syndromes. Efficacy and side effects vs delayed-action theophylline anhydride].
    Alciato P; Cantone PA; Fico D; Gagliardini R; Petrella V
    Minerva Med; 1990; 81(1-2):93-7. PubMed ID: 2314621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic effectiveness of bamifylline in elderly patients with COPD].
    Cogo R; Monzani GP; Fusillo M; Vota M
    Minerva Med; 1991 Mar; 82(3):115-8. PubMed ID: 2006029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Slow release salbutamol and Tedral in the treatment of reversible airways obstruction.
    Lal S; Bhalla KK; Davey AJ
    Postgrad Med J; 1971 Mar; 47():Suppl:89-92. PubMed ID: 4929401
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of obstructive respiratory tract diseases. Study of afonilum retard in 3,512 patients].
    Eichhorn J; Perré R
    Med Welt; 1982 Dec; 33(50):1834-7. PubMed ID: 6762480
    [No Abstract]   [Full Text] [Related]  

  • 10. Theophylline: taking it to a new level.
    Messerschmidt K
    S D J Med; 1996 Jun; 49(6):201-2. PubMed ID: 8693341
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bronchodilators: theophylline derivatives].
    Neijens HJ
    Ned Tijdschr Geneeskd; 1986 Nov; 130(46):2068-71. PubMed ID: 3796739
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of Unilair in general practice conditions. Treatment of chronic obstructive airway diseases with theophylline].
    Gregori P; Hader S; Samiri H; Wiemann M; Yousif MJ; Kiebart M
    Fortschr Med; 1997 Jan; 115(1-2):54-5. PubMed ID: 9102383
    [No Abstract]   [Full Text] [Related]  

  • 13. [Theophylline--once or twice daily?].
    Schoch C; Menz G; Virchow C
    Fortschr Med; 1987 May; 105(16):319-22. PubMed ID: 3301601
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of a new delayed-release anhydrous theophylline by single daily administration in the treatment of reversible bronchial obstruction. Comparison with a delayed-release preparation administered twice daily].
    Baronti A; Verdiani P; Di Carlo S
    Clin Ter; 1987 Sep; 122(6):437-40. PubMed ID: 2972456
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative studies of atropine methonitrate and its combination with reproterol in chronic airway obstruction.
    Macha HN; Aurich R
    Arzneimittelforschung; 1982; 32(7):774-6. PubMed ID: 6751338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study of reproterol in patients with obstructive pathology of the airways].
    Puzio E; Montanero F; Mosca L; Caserta L; Russo V
    Clin Ter; 1985 Jan; 112(2):141-4. PubMed ID: 3893858
    [No Abstract]   [Full Text] [Related]  

  • 17. [Why is Etaphylline not better in chronic aspecific respiratory disease?].
    Zuidema J; Merkus FW
    Ned Tijdschr Geneeskd; 1979 Sep; 123(35):1527-8. PubMed ID: 492369
    [No Abstract]   [Full Text] [Related]  

  • 18. [The relationships between the broncholytic and diuretic effects of theophylline in patients with obstructive lung diseases combined with oxalosis].
    Pospekhova GP; Kaiukov IG; Sinitsina TM; Razorenova TS
    Ter Arkh; 1997; 69(3):47-9. PubMed ID: 9229830
    [No Abstract]   [Full Text] [Related]  

  • 19. [Obstructive airway diseases. Basic therapy with pure theophylline in retard form].
    Pollert I
    Fortschr Med; 1982 Mar; 100(12):547-50. PubMed ID: 7042500
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of methacholine-induced bronchoconstriction with reproterol, a new beta agonist-xanthine derivative.
    Klaustermeyer WB; Kuhn GJ; Santiago SM; Wehiky I; Hunt EJ
    Ann Allergy; 1981 Apr; 46(4):189-92. PubMed ID: 7011112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.